Yan Cheng

发表

The key roles of organelles and ferroptosis in Alzheimerʼs disease

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2022, Journal of neuroscience research.

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2021, Frontiers in Pharmacology.

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer

P. Zhang, Dongqing Huang, Yan Cheng, 2022, Frontiers in Cell and Developmental Biology.

The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2022, Frontiers in Aging Neuroscience.

Isoliensinine induces cervical cancer cell cycle arrest and apoptosis by inhibiting the AKT/GSK3α pathway

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2021, Oncology letters.

Isoliensinine: A Natural Compound with “Drug-Like” Potential

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2021, Frontiers in Pharmacology.

Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2022, Frontiers in Pharmacology.

From Microbiome to Inflammation: The Key Drivers of Cervical Cancer

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2021, Frontiers in Microbiology.

Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions

Hui-Zhi Long, Yan Cheng, Zi-Wei Zhou, 2022, Drugs in R&D.

Pharmacokinetics, Bioequivalence, and Safety of 2 Formulations of Hydroxychloroquine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Yan Cheng, Dan-Dan Wen, Feng-Jiao Li, 2022, Clinical pharmacology in drug development.

Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure

Cai-xia Li, Hui-Zhi Long, Yan Cheng, 2023, European Journal of Clinical Pharmacology.